Enzyme and Metabolic Engineering Enable High-Level δ-Cadinene Production in Serratia marcescens
ACS Synthetic Biology · 05.11.2026
DOI: 10.1021/acssynbio.6c00568 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 05.11.2026. Verfasst von Bingshuo Zhang und 7 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
δ-Cadinene is a bicyclic sesquiterpene with fruity and herbal aromas that is widely used in flavors, fragrances, and pharmaceuticals. In this study, Serratia marcescens HBQA7, which carries an integrated MVA pathway and tolerates terpenoid toxicity, was used as the chassis strain. Rational design and site-directed mutagenesis of δ-cadinene synthase from Gossypium arboreum yielded a high-yield variant, G531V. In addition, mutations at key residues S409A, Y411A, D452N, and G531E led to the formation of hedycaryol and germacrene D-4-ol as byproducts. By further constructing fusion proteins and balancing the metabolic flux, we increased the yield to 5.98 g/L after 48 h of shake-flask fermentation. In a 5 L bioreactor, 100 h of fed-batch fermentation yielded a final δ-cadinene titer of 55.7 g/L, the highest level of microbial δ-cadinene synthesis reported to date.
Zitieren
APA
Zhang, B., Wang, L., Lu, Y., Fan, T., Wu, S., Zhou, X., Yang, T., & Cai, Y. (2026). Enzyme and Metabolic Engineering Enable High-Level δ-Cadinene Production in Serratia marcescens. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00568
Vancouver
Zhang B, Wang L, Lu Y, Fan T, Wu S, Zhou X, et al. Enzyme and Metabolic Engineering Enable High-Level δ-Cadinene Production in Serratia marcescens. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.6c00568
BibTeX
@article{Zhang2026,
author = {Zhang, Bingshuo and Wang, Long and Lu, Yao and Fan, Tai-Ping and Wu, Shengfang and Zhou, Xiuwen and Yang, Tian and Cai, Yujie},
title = {Enzyme and Metabolic Engineering Enable High-Level δ-Cadinene Production in Serratia marcescens},
journal = {ACS Synthetic Biology},
year = {2026},
doi = {10.1021/acssynbio.6c00568}
}
EUVIMED